• Publications
  • Influence
Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study
BackgroundGiven that treatments for chronic lymphocytic leukaemia (CLL) are palliative rather than curative, evaluating the patient-perceived impacts of therapy is critical. To date, no utilityExpand
  • 69
  • 8
  • PDF
Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis.
OBJECTIVES To evaluate the cost-effectiveness of bendamustine compared with chlorambucil as first-line treatment for patients with chronic lymphocytic leukemia who would be considered unsuitable forExpand
  • 17
  • 4